Device for multi-stage synthesis of organic molecules

Abstract

To provide an improved device for producing oligonucleotides and polypeptides which overcomes batch process limitations.SOLUTION: A device for multi-stage synthesis of organic molecules comprises the following in combination:: (a) a plurality of reaction vessels; (b) a plurality of fluid reservoirs; (c) valve elements associated with the fluid reservoirs; (d) a fluid supply device for providing a feed stream from the fluid reservoir to the vessels; (e) a plurality of devices capable of monitoring a chemical composition of effluent from the plurality of the vessels; and (f) a conveyor having a programmed pattern suitable for sequentially conveying the vessels from a fluid engagement with one fluid reservoir to the next fluid reservoir according to the programmed pattern.SELECTED DRAWING: Figure 1

Description

[Technical field]

[0001] This application claims the benefit of U.S. Provisional Application No. 62 / 831,853, filed April 10, 2019, the disclosure of which is incorporated herein by reference. [Background technology]

[0002] The present embodiments relate to systems and methods for synthesizing molecules, more particularly, the present embodiments relate to devices and methods for synthesizing biological polymers such as polypeptides and oligonucleotides, however, it should be understood that the present embodiments are also applicable to other similar applications.

[0003] An oligonucleotide is a polymer consisting of a sequence of nucleosides, which contain a sugar and a nucleobase. Each nucleoside is spaced from the adjacent nucleoside by an internucleosidic linkage, which effectively serves as the link between the nucleosides. The sugar may be a deoxyribose, ribose, or a pentose, such as 2'-0-substituted ribose. Many different bases and substituted bases can be used, the four most common being adenine, cytosine, guanine, and thymine (abbreviated A, C, G, and T, respectively). The internucleoside linkage is most commonly a phosphate, which may be substituted at the non-bridging oxygen atom with various substituents, most commonly sulfur or an alkyl, ester, or amide group.

[0004] Oligonucleotides are one of the most important and common reagents used in biotechnology laboratories engaged in research, diagnosis and therapy. The high demand for oligonucleotides comes from their specificity for complementary nucleotide sequences in DNA or RNA obtained from biological samples. Different methods are used to synthesize oligonucleotides, including the phosphoramidite method, the phosphotriester method and the H-phosphonate method, each of which is commonly known in the field of biochemistry.

[0005] Solid-phase-based multi-step synthesis of complex organic molecules using controlled fluidics via a fixed bed is one popular methodology for nucleic acid synthesis. This general technique has been widely applied to the synthesis of peptides, oligonucleotides and similar long-chain biological polymers. A comprehensive discussion of the chemistry and synthesis techniques for oligonucleotide production is provided in E. Paredes, V. Aduha, KL. Ackley, and H. Cramer, "Manufacturing of Oligonucleotides", Comprehensive Medical Chemistry, 3rd Edition, 2017, Elsevier Inc., which is incorporated herein by reference.

[0006] Commercial-scale production of a wide variety of oligonucleotides is becoming increasingly important as these materials move out of the laboratory and into mainstream therapeutic use. Commercially available oligonucleotides are typically at least 6 nucleotides in length and sometimes 12-50 nucleotides in length, with 15-30 nucleotides being the most common length.

[0007] In one system for producing oligonucleotide molecules, a solid support can be provided in a reaction vessel and multiple dimethoxytrityl (DMT) protected nucleosides can be immobilized on the solid support. A deprotecting agent that acts via a detritylation mechanism is added to remove the DMT from the nucleoside to "deprotect" the hydroxyl. As a result, the nucleoside at the end of the sequence has one hydroxyl group ready to receive the next amidite. A nucleoside phosphoramide (hereinafter referred to as an "amidite") dissolved in a solvent such as acetonitrile (ACN) is introduced into the vessel. An activating agent can be introduced into the vessel along with the amidite. The phosphorus in the amidite combines with the oxygen in the hydroxyl, thereby providing a support-bound nucleotide. After the support-bound nucleotide is formed, excess amidite can be washed out of the vessel with ACN. An oxidizing agent can then be added to convert the trivalent phosphorus to a pentavalent phosphorus. After the oxidizing agent has been flushed away, a capping agent can be added to block unprotected hydroxyls from reacting with the amidites introduced at a later stage. ACN can be reintroduced to wash away the capping agent. These steps can be repeated multiple times to create an oligonucleotide chain growing from the support-bound nucleoside.

[0008] Conventional synthesizers use a flow-through design where the various lines, pumps, and valves are constantly filled with liquid, and the liquid is introduced into a vessel called a column. A column is typically a flow-through device where the newly introduced liquid replaces the previously introduced liquid. Large manufacturing facilities often achieve high throughput by using an array of synthesizers in a batch process. These synthesizers are typically configured to perform the individual steps of the cycle of adding monomers in succession, which can be performed in parallel for several different oligonucleotides. Thus, a series of reactions for multiple oligonucleotides is performed such that detritylation is performed for each oligonucleotide, then coupling is performed for each oligonucleotide, then capping is performed for each oligonucleotide, and then oxidation is performed for each oligonucleotide. This cycle is then repeated until the full-length oligonucleotide is obtained.

[0009] A widely accepted solid-phase synthesis approach can be used to produce biopolymers (e.g., oligonucleotides, peptides, etc.) on a large scale. In this method, the starting monomers are attached to an insoluble matrix via a labile linker. To this matrix, the necessary reactants and additional reactive monomers are added to elongate the oligomeric compound onto the insoluble beads. Specifically, the solid-phase synthesis cycle for the production of oligonucleotides can generally be carried out in four repetitive steps. First, the solid support carrying the first nucleoside or auxiliary residue is placed on the solid support housing. The support is then treated with a deprotection agent solution to remove the masking group, typically the DMT protecting group on the hydroxyl group. The newly unmasked hydroxyl group is free to react in a subsequent step with the next desired residue in the oligomer sequence. In this case, the next residue is added as a phosphoramidite monomer mixed with an activator used to facilitate the reaction. The newly generated phosphotriester is not stable enough for the remainder of the synthesis, so it is generally stabilized by oxidation, thiolation, or other methods. Before resuming the next cycle, unreacted species are inactivated by the use of a capping reagent, which remasks the unreacted hydroxyl groups and prevents further extension in the subsequent coupling cycle. By repeating the four steps (unmasking, coupling, linkage stabilization, and capping), oligonucleotides of various lengths can be generated. The complex process of solid-phase oligomer synthesis can be simplified by using a solid-phase synthesis apparatus.

[0010] Large-scale nucleic acid synthesis using a single large column requires that the length of the support layer in the flow direction (hereinafter referred to as the "column length") be long or that the diameter be wide. However, both the column diameter and column length are limited due to flow distribution and high operating back pressure. Uniform mass transfer is difficult under such conditions. Therefore, there is a natural limit to the feasible column size, and therefore the production size. Thus, the length of typical commercially available oligonucleotides is limited to 15-40 Mer. Summary of the Invention [Problem to be solved by the invention]

[0011] The demand for oligonucleotides is constantly expanding, and therefore it is desirable to have the ability to produce as many oligonucleotides as possible inexpensively, in a short time, with high quality and high yield. This disclosure describes improved continuous processes and improved apparatus for the production of oligonucleotides and polypeptides that overcome the limitations of batch processes. [Means for solving the problem]

[0012] Various details of the disclosure are summarized below in order to provide a basic understanding. This summary is not an extensive overview of the disclosure and is not intended to identify particular elements of the disclosure or to delineate the scope thereof. Rather, the primary purpose of this summary is to present some concepts of the disclosure in a simplified form prior to the more detailed description that is presented below.

[0013] According to a first embodiment, a method for nucleic acid synthesis is provided. The method uses an apparatus comprising at least one deprotection unit for performing a deprotection step, at least one coupling unit for performing a coupling step, at least one oxidation / thiolation unit for performing an oxidation or thiolation step, and at least one washing unit for performing a washing step. A number of reaction vessels or "pots" for nucleic acid synthesis are moved to said units according to a synthesis scheme of a desired nucleic acid sequence, and at least two reaction vessels are arranged in a row and acted on simultaneously in some units.

[0014] According to another embodiment, a method for nucleic acid synthesis is provided. The method uses an apparatus for multi-step synthesis of organic molecules of increasing chain length. The apparatus comprises at least one deprotection station for performing a deprotection step; at least one coupling station for performing a coupling step; at least one oxidation / thiolation station for performing an oxidation or thiolation step; at least one capping station for performing a capping step, and at least one washing station for performing a washing step. Each station comprises a suitable fluid reservoir. According to a synthesis scheme for constructing a selected nucleic acid sequence, a plurality of nucleic acid synthesis containers are moved in parallel to said stations via a conveyor device, at least one station performing a reaction requiring the longest time (R) compared to the other stations. At least the majority of the containers are moved in unison (not necessarily to all stations at the same time) between said stations according to a set time (T), and said containers remain in stations having a reaction time less than R, which is a multiple of T.

[0015] According to device embodiments of the present disclosure, there is provided an apparatus for multi-step synthesis of organic compounds, the apparatus comprising in combination: (a) a plurality of reaction vessels; (b) a plurality of fluid reservoirs; (c) valve elements associated with the fluid reservoirs; (d) a fluid supply apparatus for providing a feed stream from the fluid reservoirs to the vessels; (e) a plurality of apparatus capable of monitoring the chemical composition of the effluent from the plurality of vessels; and (f) a conveyor having a programmed pattern adapted to sequentially transport the vessels from fluid engagement with one fluid reservoir to a next fluid reservoir according to the programmed pattern.

[0016] According to yet another embodiment, there is provided an apparatus for the multi-step synthesis of organic compounds, comprising: (a) a conveyor housing a plurality of reaction vessels, the conveyor movable on or about an axis, (b) a device for moving the conveyor in stages, each incremental step docking each of the vessels with one of a plurality of fluid reservoirs, (c) a fluid supplying apparatus for supplying liquid from the fluid reservoirs to each of the vessels at each of the docking stations, (d) a drainage system for draining liquid outflow from each of the vessels at each of the docking stations into one of a plurality of designated vessels, and (e) a programmable computer for controlling the conveyor, the fluid supplying apparatus, and the drainage system.

[0017] According to additional embodiments, a reaction device for sequentially carrying out a process for constructing a biomolecule is disclosed. The device comprises a plurality of separate reaction vessels, each vessel containing a support capable of binding said molecules. A plurality of fluid reservoirs capable of containing fluids for carrying out the steps of said process are also provided. A conveyor individually places each vessel in fluid contact mode with each of said fluid reservoirs. The conveyor positions the vessels in a sequential fluid contact mode with at least a first fluid reservoir and a second fluid reservoir. The vessels can be sequentially contacted with the contents of each of said fluid reservoirs, the contents of which sequentially process said molecules. At least one operating mode of the device allows at least two of said vessels to simultaneously receive fluid from a single fluid reservoir.

[0018] According to another embodiment, a nucleic acid synthesis device is provided. The device comprises at least one detritylation station for performing a detritylation step; at least one coupling station for performing a coupling step; at least one oxidation / thiolation station for performing an oxidation or thiolation step; at least one capping station for performing a capping step, and at least one washing station for performing a washing step. Each station comprises a suitable fluid reservoir, and the stations are operated in parallel. The device allows a plurality of nucleic acid synthesis containers to be moved to the stations via a conveyor device according to a synthesis scheme for constructing at least 100M selected nucleic acid sequences.

[0019] According to another embodiment, a peptide manufacturing process is provided. The process uses a device for multi-step synthesis in which successive amino acids are brought to a carboxyl group-activated state and sequentially linked to the activated sites via their carboxyl termini. The device comprises at least one detritylation station; at least several stations for providing aliquots of appropriate amino acids; at least one station for performing a washing step; at least one station for performing a neutralization step; and at least one station for performing a coupling step. Each station contains an appropriate fluid reservoir. The process simultaneously moves a plurality of peptide synthesis vessels to the stations via a conveyor device according to a synthesis scheme for building a selected amino acid sequence. The process arranges at least two peptide synthesis vessels in a line to be acted on simultaneously at several of the stations. [Brief description of the drawings]

[0020] The following is a brief description of the drawings presented for purposes of illustrating exemplary embodiments disclosed herein and not for purposes of limiting the drawings. [Figure 1] FIG. 1 is a schematic diagram of a system according to the present disclosure. [Figure 2A] FIG. 2A provides a schematic diagram of a sequential aspect of the present disclosure. [Figure 2B] FIG. 2B provides a schematic diagram of the sequential aspects of the present disclosure. [Figure 2C] FIG. 2C provides a schematic diagram of the sequential aspect of the present disclosure. [Figure 2D] FIG. 2D provides a schematic diagram of a sequential aspect of the present disclosure. [Figure 2E] FIG. 2E provides a schematic diagram of the sequential aspects of the present disclosure. [Figure 2F] FIG. 2F provides a schematic diagram of a sequential aspect of the present disclosure. [Figure 2G] FIG. 2G provides a schematic diagram of a sequential aspect of the present disclosure. [Figure 2H] FIG. 2H provides a schematic diagram of the sequential aspect of the present disclosure. [Figure 2I] FIG. 2I provides a schematic diagram of the sequential aspects of the present disclosure. [Figure 2J] FIG. 2J provides a schematic diagram of a sequential aspect of the present disclosure. [Figure 2K] FIG. 2K provides a schematic diagram of a sequential aspect of the present disclosure. [Figure 2L] FIG. 2L provides a schematic diagram of a sequential aspect of the present disclosure. [Figure 2M] FIG. 2M provides a schematic diagram of a sequential aspect of the present disclosure. [Figure 2N] FIG. 2N provides a schematic diagram of a sequential aspect of the present disclosure. [Figure 2O] FIG. 2O provides a schematic diagram of a sequential aspect of the present disclosure. [Diagram 3] FIG. 3 provides a schematic diagram of a suitable simplified second sequential step following the process of FIG. [Figure 4] FIG. 4 provides a schematic diagram of a suitable simplified third sequential step following the process of FIG. [Diagram 5] FIG. 5 provides a schematic diagram of a suitable simplified fourth sequential step following the process of FIG. [Figure 6] FIG. 6 provides a schematic diagram of a suitable simplified fifth sequential step following the process of FIG. [Figure 7] FIG. 7 provides a schematic diagram of each of the first through fifth successive steps performed in parallel. [Figure 8] FIG. 8 is a schematic diagram showing the integration of multiple stages. [Figure 9] FIG. 9 is a schematic diagram of a reaction vessel or pot. [Figure 10] FIG. 10 is a schematic diagram showing how to deal with variations in reaction time when using a series protocol. [Figure 11]FIG. 11 is a schematic diagram showing how variance in reaction times is addressed using a parallel protocol. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0021] A more complete understanding of the components, processes and devices disclosed herein can be obtained by reference to the accompanying drawings, which are merely schematic representations based on convenience and ease of illustrating the present disclosure, and are therefore not intended to illustrate the relative sizes and dimensions of the devices or their components and / or to define or limit the scope of the exemplary embodiments.

[0022] In the following description, specific terms are used for the sake of clarity, but these terms are embodiments selected for illustration in the drawings and are not intended to define or limit the scope of the disclosure. In the following drawings and the following description, it should be understood that like reference numeral designations refer to components of similar function.

[0023] The singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise.

[0024] As used herein, the terms "about," "generally," and "substantially" are intended to encompass structural or numerical modifications that do not significantly affect the purpose of the element or number modified by such term.

[0025] As used herein, certain synthesis steps are broadly described, sometimes as specific chemical reactions. For example, the term deprotection is used to describe the step of removing masking groups, and detritylation is used to describe the specific removal of DMT (4,4'-dimethoxy) groups by acidic solutions. However, these terms can be used interchangeably to describe the steps of oligonucleotide synthesis.

[0026] As used herein, the recitation of numerical ranges by endpoints includes all numbers subsumed within that range (e.g., 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.6, 4, 5, etc.). Similarly, when multiple ranges are recited for an item, it is intended that the ranges reflect various combinations thereof (e.g., 1 to 5 or 2 to 3 also includes the ranges 1 to 3 and 2 to 5).

[0027] As used in the specification and claims, the term "comprising" can include the embodiments "consisting of" and "consisting essentially of." As used herein, the terms "comprise(s)," "include(s)," "having," "has," "can," "contain(s)," and variations thereof are intended to be open-ended transitional phrases, terms, or words that require the presence of the specified components / steps and allow for the presence of other components / steps. However, such descriptions should also be construed as describing compositions or methods as "consisting of" and "consisting essentially of" the listed components / steps, which allows for the presence of only the specified components / steps, along with any impurities that may result therefrom, and excludes other components / steps.

[0028] 1 shows the basic components of a synthesis apparatus 2 of the present disclosure. The configuration includes reactant / reagent supply vessels 4 that contain liquids for carrying out the required synthesis steps such as washing (e.g., ACN), detritylation (e.g., dichloroacetic acid (DCA) / toluene), coupling (e.g., ACN, amidite, activator), thiolation (e.g., pyridine / ACN), capping (e.g., pyridine / ACN / N-methylimidazole (NMI), and post-synthesis washing (e.g., TBA / ACN). The term reactant is used to identify liquids used to extend oligomers. The term reagent is used to identify liquids used for preparation and / or activation of synthesis processes. Multiple unlabeled supply vessels are shown to demonstrate that the synthesis apparatus can accommodate any appropriate additional supply materials required by the intended synthesis. Similarly, the illustrated materials may not be required for all synthesis processes.

[0029] The synthesis apparatus 2 further includes a pump 6 (or fluid injector) in fluid communication with the supply reservoir 4. The pump 6 provides selected reagents / reactants to valves 8 for delivery to the reaction pots 10. The valves may be block valves. A flow meter 12 may be provided to monitor the amount of reagent / reactant being introduced. The flow meter and valves may work in conjunction with a controller, such as a PLC 14, to provide fluid delivery control to provide precise amounts to each reaction pot in the reaction stations described in more detail below.

[0030] At least one analytical device 16, such as a UV spectrometer, may be associated with the apparatus to monitor steps in the molecular synthesis process. Operation and monitoring of pumps 6, flow meters 12, block valves 8, and analytical devices 16 may be performed by a programmable logic controller (PLC) 14. As one skilled in the art will appreciate, plumbing 18 is provided throughout the synthesis apparatus, but is shown in the drawings for clarity only where its presence would better convey the inventive concept. For example, plumbing may be provided to convey reaction residues from reaction pots 10 to a collection vessel 20, which may improve recycling of reagents / reactants and also allow collected materials to be reused in the process. The synthesis apparatus 2 includes a number of individual reaction pots 10, which are associated with a conveyor mechanism 22, such as a moving belt. The tops of the eleven reaction pots are arranged on the conveyor mechanism. The conveyor mechanism may be circular, linear, or zig-zag.

[0031] It is contemplated that the synthesiser components, particularly those in direct contact with the reagents / reactants, may be formed from suitable materials such as stainless steel, polyetheretherketone, and / or polytetrafluoroethylene. It is recommended that the synthesiser be manufactured in accordance with FDA regulations, e.g., cGMP, CFR 21 Part 117. It is further contemplated that the synthesiser is housed and / or operated in a controlled environment that may be purged with an inert gas such as argon or a less reactive gas such as nitrogen.

[0032] Each reaction station (see, e.g., FIG. 1) can include at least one supply vessel, at least one pump, at least one flow meter, and at least one control valve. Of course, appropriate plumbing exists to supply the appropriate reagents / reactants to the particular station. Depending on the reaction needs and reagent types, it is envisioned that each station will have the capacity to dispense associated reagents / reactants at volumes of about 10-1000 ml / min.

[0033] Each supply vessel, in combination with associated pumps, piping, flow meters, valves, analytical equipment, and collection vessels, can be considered a reaction or processing station. Any of the equipment associated with the station may be heated or cooled and / or may include a source of pressurized gas for processing the pumps, valves, piping, and / or vessels. Each station may further comprise one or more of a separation unit, a filtration unit, a membrane extraction unit, and / or a chromatography unit.

[0034] With respect to the PLC, the PLC 14 communicates with the synthesis device via wired or wireless feedback lines, allowing the PLC to maintain the position of the reaction pots in real time. Position sensors can be provided to monitor the position of the reaction pots. The PLC controls the movement of the reaction pots 10 through a reaction protocol and fluidly connects the individual pots and stations according to the programmed synthesis process.

[0035] The synthesis can also be controlled by a PLC. Instructions from the PLC control the timing, volume, flow rate and sequence of introduction of reagents / reactants to the reaction pots, thus determining the sequence of oligomer synthesis. These instructions, e.g., instructions for opening and closing various valves, instructions for moving conveyors / reaction pots, instructions for operating various pumps, instructions for monitoring flow meters or analytical devices, etc., can be tied to a master command related to the construction of long chain molecules of a specific structure.

[0036] The PLC may be programmable such that the device can prepare a "batch" of multiple reaction pots of a first long chain molecule and then be reprogrammed to prepare a batch of multiple reaction pots of a different long chain molecule.

[0037] An analytical device (or devices), such as a UV spectrometer, may be provided at some (or all) stations to analyze either or both of the reaction products in the reaction pot 10 or the residue collected from the reaction pot 10. Additionally, or as an alternative to a UV spectrometer, the system may include a liquid chromatography mass spectrometer (LCMS), a light monitor, a temperature monitor, an infrared monitor, an NMR spectrometer, and / or a Raman spectrometer for quality control. The system preferably allows reaction pots that exhibit unsatisfactory results, such as synthesis errors or incompletely reacted molecules, to be removed from the conveyor mechanism or otherwise removed from further processing steps. This allows the effects of a failed reaction step to be contained to a single reaction pot and prevented from contaminating the entire running production.

[0038] Figures 2A-O illustrate the continuous nature of the synthesis process associated with the present apparatus. Specifically, in Figure 2A, a first reaction pot 1 is introduced into a first station (pre-synthesis wash). Reaction pot 2 is then positioned to be picked up by a conveyor mechanism.

[0039] The illustrated sequence of steps is, of course, exemplary. Moreover, each step need not necessarily be performed in the exact order illustrated. For example, an amino wash at the end of each step is not required. Similarly, the illustrated steps need not be performed with the listed chemicals. Rather, alternative fluids capable of performing similar / identical functions are known in the art.

[0040] Reaction pot 1 (and subsequent pots) can contain a support such as NittoPhase® HL. A frit or filter cloth can be provided in the reaction pot to host the support. The support can contain particles having a smaller size than conventional (e.g., less than 80 μm, or less than 40 μm, or less than 1 μm, or less than 0.3 μm) because the pressure drop is relatively small considering the relatively small size of the reaction pot. Note that liquid phase synthesis is also contemplated.

[0041] Reaction pot 1 is first associated with a station for pre-synthesis washing to receive ACN. A waste collection vessel is connected to the reaction pot at the pre-synthesis station to collect excess ACN for recycling. Each station can have its own pump to introduce liquid from the supply vessel. Each station can also include its own flow meter to control the rate of fluid introduction to match the kinetics of the reaction / process occurring at that station. Furthermore, each station can include its own control valve (or a series of control valves) to ensure that the reaction pot is supplied with a sufficient amount of fluid to complete the associated reaction / process. Furthermore, multiple control valves may be provided at a station, allowing multiple reaction pots to be processed simultaneously.

[0042] In Figure 2B, reaction pot 2 enters the conveyor mechanism and is placed in the first station for pre-synthesis cleaning while reaction pot 1 transitions to the second station for detritylation. Each of reaction pots 1 and 2 can be placed in their respective synthesis stations for at least about the same amount of time. The second station may operate at a different flow rate and / or volume than the first (or subsequent) station, as may other stations in the apparatus.

[0043] The second station may include a UV spectrometer 16 or other analytical device to assess the condition of the reaction pot 1 and / or its residues. The second station is provided with a separate waste collection (recycle) container so that excess reagents can be collected and recycled, as are the other stations in the apparatus.

[0044] In Fig. 2C, the conveyor mechanism moves reaction pot 1 to a third station for a second detritylation stage where different concentrations of DCA / toluene are provided. At least substantially simultaneously, reaction pot 2 is moved by the conveyor mechanism to the second station for a first detritylation treatment, and reaction pot 3 enters the first station of the apparatus for a pre-synthesis wash. A UV spectrometer is provided to assess the content of reaction pot 1 and / or its residues in the third station.

[0045] Because the same pumps, piping, and valve equipment are used at each station with the same reagents, there is no need to drain or clean liquid residues between synthesis steps. This advantage also extends to the transition from a synthesis sequence forming a first molecule to a synthesis sequence configured to form a second molecule. This increases the processing speed and reduces waste.

[0046] In FIG. 2D, reaction pot 1 reaches the fourth station for coupling, while reaction pot 4 is picked up by a conveyor mechanism and transported to the first station for pre-synthesis cleaning. Each reaction pot 1-4 is acted on at least substantially simultaneously in each station. The coupling station is shown with three reaction pots that may have preceded reaction pot 1 (only three reaction pots are shown for illustration purposes). The use of counter-current flow provides exceptional efficiency in relation to the introduction of relatively expensive phosphoramidites. In addition, phosphoramidite waste can be reduced compared to conventional batch processing.

[0047] A reaction pot in a coupling station can move simultaneously with other reaction pots in the array, but remain in fluid communication with that coupling station for multiple active periods (i.e., the time that the reaction pot receives fluid from the station). Bidirectional flow of fluid allows multiple reaction pots to be processed simultaneously. In FIG. 2D, four reaction pots simultaneously receive amidite reaction feed thymine, ACN, and an activator (such as ethylthio-1H-tetrazole (ETT)). The amidite feed can be at a concentration equal to or greater than that required for one reaction pot. Amidites can be introduced to the first reaction pot in an amount greater than the 3:1 stoichiometric requirement. For example, phosphoramidites can be added in an amount of about 0-5.0 equivalents or about 1.5-3.0 equivalents of the reaction capacity based on the volume of the support. The excess amidites are transferred to the reaction pots connected in series. In this way, unreacted amidites from one sequentially linked reaction pot can flow to the next reaction pot and be picked up for molecular building, resulting in a significant reduction in loss of phosphoramidites compared to batch processing.

[0048] In certain synthetic processes, it may be desirable to provide intermittent washing and / or pulsed washing during the coupling process. Additionally, pulsed washing can be used to strip off unreacted amidites that may not otherwise easily flow to the downstream reaction pot. Washing can be done with liquids such as ACN or gases such as N2 or a combination of both.

[0049] The introduced amidites are added to the extension molecule. By sequentially coupling the reaction pots and then moving sequentially up the chain in a bidirectional flow, this process ensures proper molecular assembly by exposing the reaction pots to the stoichiometrically highest concentration of amidite at the last position of the coupling station. In essence, the "residual" amidite from one reaction pot is used to "pre-treat" the subsequent reaction pot, reducing waste. It should also be noted that the bidirectional flow method used in conjunction with the amidite supply station is equally suitable for use with any or all of the other stations of the synthesis apparatus.

[0050] 2E-2G show that as the reaction pots are moved downstream on the conveyor mechanism, reaction pots 5, 6, and 7 newly join the continuous progression of reaction pots, and reaction pots 2, 3, and 4 join reaction pot 1 at the thymine coupling station in a bidirectional flow arrangement.

[0051] Figures 2H and 2I show how reaction pot 1 and reaction pot 2, respectively, move sequentially to the coupling wash station. The coupling wash station can also be in a bidirectional flow configuration. An example is shown in which two reaction pots are in line and receive coupling fluid. Of course, more than two reaction pots can be connected in line. As is clear, these reaction pots are followed in sequence by new reaction pots (reaction pots 8, 9).

[0052] In Figures 2J and 2K, reaction pots 1 and 2 are moved in sequence to the thiolation station (pyridine / ACN). As can be seen, these reaction pots are followed in sequence by new reaction pots (reaction pots 10, 11).

[0053] Figures 2L and 2M show that reaction pots 1 and 2, respectively, are sequentially transferred to the capping station (pyridine / ACN / NMI / AC20), again using a bidirectional flow configuration, and as can be seen, are followed in sequence by new reaction pots (reaction pots 13, 14).

[0054] 2N and 20 show that reaction pot 1 and reaction pot 2, respectively, are sequentially moved to a post-synthesis amine wash station. These reaction pots are followed in sequence by new reaction pots (reaction pots 15, 16) in the synthesis process. After completion of the post-synthesis amine wash, the exemplary first synthesis stage can be considered complete, resulting in a number of reaction pots containing in-process molecules having a first oligonucleotide unit dT.

[0055] FIG. 3 shows the second synthesis stage where the reaction pots of the first synthesis stage are received and further processed. Preferably, the same stations used in stage 1 can be used in stage 2. In practice, it is envisaged that stations will run simultaneously for stage 1, stage 2, stage 3 etc. Certain steps may not be implemented in the second synthesis stage, such as the pre-synthesis wash and the first detritylation step. For clarity, note that stations 3, 5, 6, 7, 8 from stage 1 are reused in stage 2, and station 9 to provide cytosine is added to the protocol for stage 2.

[0056] Furthermore, any amidite can be processed in the second synthesis stage, and the synthesis of cytosine is shown. This can be achieved by the addition of a cytosine supply station 9. It is also contemplated that a complete station (supply vessel, pump, flow meter, valve block, analyzer and residue collector) is provided for the introduction of cytosine. Further stations can be added for each amidite contained in the molecule. In particular, since the synthesis apparatus can be configured to form any number of oligonucleotides, it is likely to include stations for commonly used amidites or all amidites.

[0057] Figures 4, 5 and 6 show further synthesis stages used to build longer polymers, where the reaction pots of the preceding stages are sequentially introduced to add amidites. Station 10 is provided to supply a new amidite dG. However, pump (4) is again used for the second introduction of dT in stage 4. Station 9 is used for the second introduction of dC in stage 5. Figure 5 shows a new step in the synthesis process, which also constitutes a repetition of step 1 of the protocol. Figure 6 shows a repetition of stage 2 of the sequence protocol.

[0058] This reuse of the amidite stations can be repeated as necessary to build molecules of desired structure and length. In this context, it is envisioned that molecules of 2-300Mers, or at least 100Mers, or greater than 200Mers, or greater than 300Mers can be produced (when considering polypeptides, base pairs are an appropriate measure). After synthesis of the desired molecules in multiple reaction pots, the contents can be combined in a larger storage vessel. The combined contents may be processed according to conventional oligonucleotide production / purification techniques.

[0059] The system can include more than 15 conveyor arrays handling more than 100 reaction pots to achieve molecules of desired length. In general, it is envisioned that each conveyor array will receive multiple (e.g., 7 or more) reaction pots.

[0060] It is envisioned that the reactors of the present disclosure can have a large number (e.g., more than 20) of reactions in a row and can provide multiple rows (e.g., more than 20). In this context, 400 or more reaction pots can be run simultaneously, with most pots at different stages in the molecular build. In general, exemplary reactors can have 5-25 reaction stations and include 5-10 rows.

[0061] Figure 7 illustrates the efficiency of the present synthesis apparatus. For example, it is possible to provide a single supply vessel and supply station for each step in the synthesis sequence. By providing separate pumps, flow meters, valves, and plumbing, a single reservoir can supply reaction pots at any of stages 1-5 (or more). Similarly, a single amidite reservoir can supply amidites to different steps in the synthesis sequence (e.g., thymine to stage 1 and stage 4).

[0062] Additionally, it is contemplated that reagents / reactants may be provided at different concentrations at different steps of a molecule synthesis. For example, it may be desirable to introduce more activator at stage 5 than at stage 1. Similarly, it may be desirable to add a lower concentration of coupling wash at later stages of the synthesis process. Similarly, the amount of amidite introduced may be varied depending on the number of reaction pots connected in series at a single reaction station.

[0063] Further benefits come from using each reaction station with only one type of reactant / reagent, since pumps, flow meters and valves do not need to be cleaned between steps of the synthesis process. Likewise, there is no need to empty the equipment between reaction stages. In this context, a single station (e.g., thiolation) can be used to process several reaction pots at different stages of the polymer synthesis.

[0064] It is also contemplated that the synthesis apparatus may include one of the following units in one or more stations: cleavage, deprotection, separation, filtration, membrane extraction and / or chromatography.

[0065] FIG. 8 shows that, except for the coupling station, a single pump can be used for each station, with one pump for each amidite used. Additionally, some stations can include multiblock valves capable of simultaneously feeding multiple feed streams. Taking the coupling station as an example, the multiblock valve can simultaneously feed a feed stream of dT from station 4 to the in-line reaction pots at stages 1 and 4, and a feed stream of dC from station 9 to the in-line reaction pots at stages 2 and 5. Other stations can include multiblock valves to feed different concentrations of feed streams to different stages of the synthesis process. For example, it may be desirable to feed a higher concentration of NMI to the capping station at stage 5 than to stage 1. Note that for clarity, "stage..." includes a schematic diagram of a conveyor plate mechanism (see 120 in FIG. 9 below) that includes "U" shaped inlet / outlet tubes suitable for receiving the reaction pots. This conveyor plate mechanism allows the reaction pots to be arranged in the proper array and spacing to most efficiently build the desired biological polymer. Each stage array can be a separate plate where the reaction pots are removed from the first plate array and attached to the next plate array, or the arrays can be mechanically integrated.

[0066] FIG. 9 shows an exemplary reaction pot 100. The pot 100 can include a vessel 112 containing a reaction bed 113. The top surface 114 of the pot can include an inlet 116 for introducing a liquid feed stream into the top of the reaction pot, and an outlet 118 for removing liquid from the lower region of the pot after passing through the reaction bed 113. Gas can be introduced through the inlet 116 (or another passage) to aid in removal. The reaction pots 100 can be arranged to mate with a plate 120 located at each station and including a sealable mating joint. The plate 120 can move vertically to engage / disengage the reaction pot 110, which moves horizontally from station to station. However, it is envisioned that the reaction pot transport mechanism can receive pots of different sizes and shapes. The reaction pots can be single-use (e.g., disposable containers and / or bags) or reusable, depending on the needs of the synthesis being performed.

[0067] Exemplary reaction pot sizes can be about 1-100 mm inner diameter, or about 10-50 mm inner diameter, and up to 150 mm height. The effective dimensions of the support within the reaction pot can be specified. For example, the support in a solvent-swollen state can be about 0-150 mm, or about 5-30 mm, or about 10 mm-40 mm high, and greater than 0 mm to about 100 mm, or about 10 mm-50 mm in diameter. However, it should be noted that the shape of the vessel need not be cylindrical.

[0068] Relatively small volume (e.g. 15 cm 3 By operating the system with multiple reaction pots (less than 2,000 mm diameter, 200 mm height) the mass transfer of the reactions occurring in each reaction pot is improved. The improved mass transfer has advantages such as a pressure drop of less than about 5 bar per reaction pot. Nevertheless, when considering the entire system, the use of many reaction pots requires a larger reaction volume (e.g. 2,000 mm diameter, 200 mm height = 3,140 cm) than is currently practical in batch processes. 3) is provided, whereas 200 reaction pots, each 40 mm in diameter and 150 mm in height, are provided for a total capacity of 9,420 cm 3 Provide the volume of.

[0069] The reaction pot may be equipped with temperature control, mixing, pressure regulation and / or pH control. It may be desirable to vary the conditions (e.g., temperature) of the reaction pot between stations to optimize the environment for the process / reaction being performed. The reaction pot may also include probes for monitoring at least one of temperature, pressure, pH, conductivity and time.

[0070] The reaction pots can also be individually marked (e.g., barcoded) for identification. In this way, aspects of the synthesized molecule in each reaction pot can be stored in a database. This information can include, for example, production stage, expected or actual molecular structure, production date, purity, etc.

[0071] In certain embodiments, the reaction pots are moved between stations in unison (not necessarily at all stations at the same time) according to a set time (T). However, each step of the synthesis process may not be completed at the same time. Furthermore, at least one step may have the longest reaction time (R). Thus, the reaction pot may move between positions but remain at a station with a reaction time less than R for a time that is a multiple of T (the multiple may be an integer). In this context, at some stations, the reaction pot may be held at the station while the station is inactive.

[0072] In start-up mode, vessels can be transferred after a period of reaction time which is a fraction of T until at least one vessel is associated with each station. After the start-up, at least one reaction vessel can be placed at each station and a normal transfer rate T is initiated. Depending on the molecules being formed, it is envisioned that each reaction pot will be transferred every few seconds to 10 minutes, or even ½ to 5 minutes.

[0073] Figure 10 shows the concept of the synthesis apparatus of the present invention operating serially according to set time intervals. Furthermore, each step is configured to have pot positions equal to the expected reaction time. For example, the detritylation step has a reaction time of 3 minutes and corresponding three pot positions, which can receive feed liquids (e.g. DCA / toluene) from one feed at a time. In this configuration, each pot can follow the previous pot throughout the assembly.

[0074] In Fig. 11, the concept of the synthesis apparatus of the present invention is shown to operate in parallel according to a set time interval. Moreover, the number of pots in a station corresponds to the associated reaction time. For example, two pots remain in the first detritylation station, and DCA / toluene is fed sequentially from the first of the two pots to the second. In this configuration, the pots do not follow the previous pot, but move to the position of the longer reaction step. In both the protocols of Fig. 10 and Fig. 11, the intention of this configuration is to place each pot in a station for a time sufficient to complete the reaction. In that context, it is envisioned that serial and / or parallel strategies can be used together or alternatively in the stations.

[0075] At the end of the construction of the desired macromolecule, the procedure contemplates removing the reaction pot containing the desired macromolecule from the synthesizer array. Similarly, the procedure contemplates that a station that has completed supplying the last reaction pot can stop introducing its designated reagent / reactant. In this context, it is envisioned that each station can include a supply of cleaning fluid (potentially from a centralized reservoir of cleaning fluid). In this way, the pot that is finishing the cycle can receive the cleaning fluid that is used to finish each station in the array following the reaction pot that last constructed the macromolecule. An exemplary cleaning fluid is ACN.

[0076] It is also contemplated that excess reagents / reactants from individual stations can be fed to different stations along the row, or even to stations in different rows, for recycling. This can be done at any point in the build of the macromolecule, and when employed at the end of a cycle, a terminated reaction station can further feed the array of active reaction stations. For example, rather than recycling ACN from station 1 back to the feed vessel of station 1, it can be recycled to station 5 (or other suitable) to conserve raw materials and improve operational efficiency, especially at the end of the process.

[0077] Although specific reagents and reactants are illustrated, the disclosure is not limited to these examples or sequences: rather, one of skill in the art will recognize that countless variations in synthetic sequences are feasible.

[0078] The synthesis device may also be configured to distribute reaction solutions for synthesizing a polypeptide. The process of peptide synthesis on a solid support generally involves building a peptide from the carboxyl terminus. The peptide is attached to the solid support via its carboxyl terminal amino acid and further comprises a protecting group on the amino terminal α-amino group. The protecting group is then cleaved from the peptide to form a deprotected peptide. A monomeric amino acid containing a protected α-amino group is then contacted with the deprotected peptide under conditions that form a peptide bond between the α-amino group of the deprotected peptide and the α-carboxyl group of the monomeric amino acid. The monomeric amino acid may be provided in an activated form or an activating reagent may be added to the amino acid and the elongated peptide. Washes may be performed between steps to remove the reagent. The cycle of deprotecting the next amino acid and coupling additional amino acids may be repeated until a peptide of the desired length is synthesized. Any reactive side chains of the amino acids are generally protected by chemical groups that can survive the coupling and deprotection process of the α-amino group. However, the protecting groups of these side chains may be removed at the end of the synthesis. The array of stations and the schedule by which the arrays interact with one another can be correlated according to the teachings of this specification and known reaction schemes for peptide synthesis, such as those described in Goodman et al., Synthesis of Peptides and Petidomimetics, Vol. E22a, Georg Thieme Verlag, Stuttgart, 2002.

[0079] The following examples are offered by way of illustration and not by way of limitation.

[0080] Oligonucleotides are produced using the apparatus described herein by following physical steps that include delivering fluids to and draining waste from multiple reaction pots, and a computer is programmed to deliver the appropriate reactants to designated reaction pots in a designated order.

[0081] Oligonucleotide synthesis includes deprotection, condensation, oxidation, and capping. Deprotection is the removal of the acid-labile DMTr group from the 5'-OH of the sugar moiety. Condensation couples excess activated monomers to the growing chain. Oxidation is the oxidation of the 3'-5' internucleotide phosphite triester linkage to the more stable phosphotriester linkage. The polymer is then treated to remove the protecting groups, thereby generating phosphodiester linkages. The capping step is the capping of the uncondensed 5'-hydroxyl groups as acetate esters. The general protocol is: 1. Washing the support; 2. Dispensing a liquid containing a deblocking agent to remove the protecting groups; Draining; 3. Dispensing a liquid containing the protected nucleotide and a coupling activator; Draining; 4. Dispensing a liquid containing a capping agent; Draining the liquid; Washing the support; Draining the liquid containing the oxidizing agent. The steps are repeated until the nucleotide sequence is complete.

[0082] Polypeptide synthesis may involve the addition of amino acids to a nascent polypeptide chain in 1. deprotection by removing the protecting group (Fmoc or Boc) to make available the α-amino group at the end of the growing peptide chain; 2. activating the amino acid residue to an active ester and then coupling by forming an amide bond with the deprotected α-amino group at the end of the growing peptide chain; and 3. capping the unreacted α-amino group with the same reagents as in DNA / RNA synthesis. In Fmoc synthesis, the base-labile protecting group (Fmoc) is removed with each cycle. At the end of the synthesis, the side chain protecting groups are removed with weak acid and the bond that anchors the peptide to the support is also cleaved. In Boc chemistry, the Boc protecting group is acid labile and can be removed with mild acid. The final deprotection and cleavage steps use strong acid.

[0083] The protocol for peptide synthesis using Fmoc chemistry can include the following steps: 1. Deprotection (at least once) - piperidine, 2 times - 7 min; 2. Drain; 3. Wash (at least once) - N-methylpyrrolidone (NMP) or dimethylformamide (DMF), 6 times; 4. Coupling - 18 sec activation + 35 min coupling; 5. Drain; 6. Capping [optional] - 1 min; 7. Drain; 8. Wash (at least once) - NMP or DMF, 3 times. Steps 1 to 8 are repeated until the amino acid sequence is completed. The protocol for peptide synthesis using Boc chemistry may include the following steps: 1. Wash (at least once) - chloromethane (DCM), 1 time; 2. Deprotection (at least once) - trifluoroacetic acid (TFA), 2 times - 6 min; 3. Drain; 4. Wash (at least once) - chloromethane (DCM), 1 time; 5. Wash (at least once) - NMP or DMF, 6 times; 6. Coupling - 18 s activation + 35 min coupling; 7. Drain; 8. Capping [optional] - 1 min; 9. Drain; 10. Wash (at least once) - NMP or DMF, 3 times. Steps 1 to 10 are repeated until the amino acid sequence is completed.

[0084] The exemplary embodiments have been described with reference to preferred embodiments. Obviously, modifications and alterations may occur to others in light of the above detailed description. It is intended that the exemplary embodiments be construed as including all such modifications and alterations insofar as they come within the scope of the appended claims or the equivalents thereof.

[0085] To assist the Patent Office and readers of this application and any resulting patent in interpreting the claims appended to this application, applicants do not intend to invoke 35 U.S.C. 112(f) in any of the appended claims or claim elements, unless the words "means for" or "step for" are expressly used in a particular claim.

Claims

1. 1. An apparatus for multi-step synthesis of organic molecules, comprising in combination: (a) a plurality of reaction vessels; (b) a plurality of fluid reservoirs; (c) valve elements associated with the fluid reservoirs; (d) a fluid supply for providing a feed stream from the fluid reservoirs to the vessels; (e) a plurality of devices capable of monitoring the chemical composition of the effluent from the plurality of vessels; and (f) a conveyor having a programmed pattern suitable for sequentially transporting the vessels from fluid engagement with one fluid reservoir to a next fluid reservoir according to a programmed pattern.

2. 10. The apparatus of claim 1, wherein each fluid reservoir comprises a reaction and / or processing station, at least one station being simultaneously connected to at least two vessels in a row.

3. 3. The apparatus of claim 2, wherein the fluid reservoir is connected to the reaction vessel in a counter-current flow arrangement or a co-current flow arrangement.

4. 10. The apparatus of claim 1 comprising at least 100 reaction vessels.

5. 10. The apparatus of claim 1, comprising at least X fluid reservoirs and at least Y containers, where Y>X.

Images